GlaxoSmithKline Share Price (GSK)

1,490.50 +6.10 (+0.41%) delayed: 7:14AM GMT
Bid price 1,475.00 Open price 0.00
Ask price 1,506.00 Prev close 1,484.40
High price 0.00 Spread 2.06%
Low price 0.00 Volume 0

Register now for FREE live GlaxoSmithKline share prices, GlaxoSmithKline stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get GlaxoSmithKline Level 2 Data, indepth research tools and investor commentary for GlaxoSmithKline (GSK) and other London Stock Exchange equities.

GlaxoSmithKline Share Price Chart

Advanced Charts >>

Register now for FREE GlaxoSmithKline share price charts

GlaxoSmithKline Share Price Information

Name GlaxoSmithKline Epic GSK
Sector Pharmaceuticals & Biotechnology ISIN GB0009252882
Activites GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company with a powerful combination of skills and resources that provides a platform for delivering strong growth in today's rapidly changing healthcare environment. Headquartered in the UK and with operations based in the US, the new company is one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market. GSK also has leadership in four major therapeutic areas - anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic. In addition, it is a leader in the important area of vaccines and has a growing portfolio of oncology products. The company also has a Consumer Healthcare portfolio comprising over-the-counter (OTC) medicines, oral care products and nutritional healthcare drinks, all of which are among the market leaders. GSK has over 100,000 employees worldwide. Of these, over 40,000 are in sales and marketing, the largest sales force in the industry. Around 35,000 employees work at 82 manufacturing sites in 37 countries and over 15,000 are in R&D. GSK R&D is based at 24 sites in 11 countries. The company has a leading position in genomics/genetics and new drug discovery technologies. The GSK R&D budget is about £2.8bn/$5bn. Index FTSE 100

GlaxoSmithKline Key Numbers

Latest Share Price (p) 1,490.50 Net Gearing (%) 87.01
Market Capitalisation (£m) 74,893.87 Gross Gearing (%) 93.81
Shares in issue (m) 4,964.46 Debt Ratio 88.30
P/E Ratio 48.05 Debt-to-Equity Ratio 0.50
Total dividends per share (p) 80.00 Assets / Equity Ratio 16.16
Dividend Yield (%) 5.30 Price to book value 21.47
Dividend cover (x) 0.39 ROCE (%) 11.82
Earning per share (p) 31.40 EPS Growth (%) 67.02
52 week high / low 1,648.80 / 1,236.40 DPS Growth (%) 0.00

GlaxoSmithKline Director Deals

Dec.Date Type Director Pos No. of Shares
15/01/2019 DRI Simon Dingemans FD 1,051
15/01/2019 DRI Emma Walmsley CEO 1,536
15/01/2019 DRI Simon Dingemans FD 1,994
15/01/2019 DRI Simon Dingemans FD 1,457
15/01/2019 DRI Emma Walmsley CEO 1,588

More GlaxoSmithKline Director Deals >>

GlaxoSmithKline Company News

17:20 15/01/2019

Director Deals - GlaxoSmithKline PLC (GSK)

Simon Dingemans, Financial Director, has re-invested 1,051 shares in the company on the 11th January 2019 at a price of 1528.75p. The Director now holds 694,100 shares. Story provided by StockMarketWire.com Director deals data provided by www.sharesmagazine.co.uk

17:20 15/01/2019

Director Deals - GlaxoSmithKline PLC (GSK)

Emma Walmsley, Chief Executive Officer, has re-invested 1,536 shares in the company on the 11th January 2019 at a price of 1528.75p. The Director now holds 526,361 shares. Story provided by StockMarketWire.com Director deals data provided by www.sharesmagazine.co.uk

17:15 15/01/2019

Director/PDMR Shareholding

RNS Number : 1864N GlaxoSmithKline PLC 15 January 2019   GlaxoSmithKline plc   (the   ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Ms E N Walmsley b)...

More GlaxoSmithKline Company News >>

Register now for FREE GlaxoSmithKline company news

GlaxoSmithKline Share Price Discussions

more than 1 year ago

Glaxo trading near low (GSK)

there seems to be some heavy resistance around these level with a lot of potential upside.

more than 1 year ago

Traders Thread - Friday 13th February (GSK)

UK PreMarket Futures FTSE +8 DAX Unch DOW +26 S&P +2 Nasdaq +5 1 Day 2 Day...

more than 1 year ago

Traders Thread - Friday 13th February (GSK)

UK PreMarket Futures FTSE +8 DAX Unch DOW +26 S&P +2 Nasdaq +5 1 Day 2 Day...

Register now for FREE GlaxoSmithKline share price discussions